The effectiveness and safety of cadonilimab in the first-line treatment of recurrent or metastatic cervical cancer: A retrospective, real-world study
用户5TLJU3iD5n3A
2个月前
86
10
已完结
1. 系统已在2025-07-30 11:27:50对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规